Cargando…
Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
Breast cancer stem cells (BCSCs), also known as breast cancer initiating cells, are reported to be responsible for the initiation, progression, therapeutic resistance, and relapse of breast cancer. Conventional therapeutic agents mainly kill the bulk of breast tumor cells and fail to eliminate BCSCs...
Autores principales: | Lv, Li, Shi, Yonghui, Wu, Junyan, Li, Guocheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914063/ https://www.ncbi.nlm.nih.gov/pubmed/33654398 http://dx.doi.org/10.2147/IJN.S282110 |
Ejemplares similares
-
Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota
por: Karavolos, Michail, et al.
Publicado: (2016) -
Nanosized Drug Delivery Systems to Fight Tuberculosis
por: Bourguignon, Tom, et al.
Publicado: (2023) -
IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery
por: Jalilian, Amir R., et al.
Publicado: (2022) -
Editorial: Nanosized Drug Delivery Systems: Colloids and Gels for Site Specific Targeting
por: Ehrbar, Martin, et al.
Publicado: (2020) -
Antitumor therapy for breast cancer: Focus on tumor‐associated macrophages and nanosized drug delivery systems
por: Zhan, Cuiping, et al.
Publicado: (2023)